Table: Wakamoto Pharm -6-MTH parent results

Wakamoto Pharmaceutical

04/11/2015 06:00

Nov 4 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             5.43                5.21             11.50     
                 (+4.2 pct)          (+5.6 pct)       (+8.3 pct)   
  Operating        18 mln            loss 50 mln        130 mln    
                                                      (+26.5 pct)  
  Recurring        103 mln             27 mln           200 mln    
                (+272.0 pct)         (-24.1 pct)      (-14.4 pct)  
  Net              61 mln              11 mln           110 mln    
                (+441.3 pct)        (+111.9 pct)      (+32.0 pct)  
  EPS             1.77 yen            0.33 yen         3.17 yen    
  Ann Div                             3.00 yen         3.00 yen    
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen         3.00 yen    
   
  NOTE - Wakamoto Pharmaceutical Co Ltd is a pharmaceutical manufacturer with ethical drugs as mainline.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))